@article{28197,
  keywords = {Immunotherapy (MIP vaccine), Clinical improvement, Chemotherapy (WHO- MDT), Borderline leprosy},
  author = {Kamal R and Pathak V and Kumari A and Natrajan M and Katoch K and Kar H K},
  title = {Addition of Mycobacterium indicus pranii (MIP) vaccine as an immunotherapeutic with standard chemotherapy in borderline leprosy: A double blind study to assess clinical improvement (A preliminary report).},
  abstract = {<p>The response of leprosy patients to chemotherapy (WHO-Multi Drug Therapy) though generally good and predictable, exhibits variations in a section of cases. Some cases show a dramatic response while others show a slower response such variations are a reflection of the immune status of the host. This article is protected by copyright. All rights reserved.</p>
},
  year = {2016},
  journal = {The British journal of dermatology},
  issn = {1365-2133},
  doi = {10.1111/bjd.14971},
  language = {eng},
}